Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy

Author(s):
Driessen, C.M.L.; Leijendeckers, J.; Snik, A.; Graaf, W.T.A. van der; Boer, J.P. de; Gelderblom, H.; Kaanders, J.H.A.M.; Takes, R.; Herpen, C.M.L. van
Published
2019
Publication type
Article / Letter to editor
chemoradiotherapycisplatinhigh doseintermediate doseototoxicity
Date issued
2019-02-28
Language
English
Is part of
Head and Neck (2019), Vol. 41, no. 2, p. 488-494
hdl
1887/119560
doi
10.1002/hed.25434